SLC5A2 and metabolic dysfunction-associated steatohepatitis: Future research should aim at assessing the accuracy of using AAA-1 to predict histology-based NAFLD/NASH/cirrhosis diagnoses, and at defining if AAA-1 could represent actionable therapeutic targets through SGLT-2 inhibition in order to promote the development of precision medicine in the field of NAFLD.